Former AveXis executives launch gene therapy startup with uncommon targets

Retrieved on: 2021-02-25 12:00:00

Tags for this article:

Branches of biology

Life Sciences

Health sciences

Spinal muscular atrophy

Applied genetics

Drug discovery

Gene therapy

Emerging technologies

AveXis

Adeno-associated virus

Novartis

Onasemnogene abeparvovec

Sean Nolan

Click the tags to see associated articles and topics

Former AveXis executives launch gene therapy startup with uncommon targets. View article details on HISWAI: https://www.biopharmadive.com/news/jaguar-gene-therapy-startup-former-avexis-executive/595691/

Excerpt

BioPharma Dive 5 questions facing gene therapy in 2021 offsite link; Spectrum News A quest for Quincy: Gene therapies come of age for some forms ...

Article found on: www.biopharmadive.com

View Original Article